An engineered prodrug selectively suppresses β-lactam resistant bacteria in a mixed microbial setting
A. M. Duda, H. R. Ma, C. A. Villalobos, S. A. Kuhn, K. He, S. R. Seay, A. C. Jackson, C. M. Suh, E. A. Puccio, D. A. Anderson, V. G. Fowler, L. You, K. J. Franz
This paper engineers a prodrug that selectively suppresses β-lactam-resistant bacteria in mixed cultures by exploiting ESBL activity.
ACS Infectious Diseases · Jun 12, 2025Peer-reviewedMicrobiology